Glue (Toluene) Abuse: Increased QT Dispersion and Relation with Unexplained Syncope

REFERENCES

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. rev. (DSM—IV). American Psychiatric Association, Washington, DC 2000; 239
   Google Scholar
• Barr C. S., Naas A., Freeman M., et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327–329
   PubMed Web of Science ®Google Scholar
• Bass M. Sudden sniffing death. J. Am. Med. Assoc. 1970; 212: 2075–2079
   PubMed Web of Science ®Google Scholar
• Bazett H. C. An analysis of time-relations of eletrocardiograms. Heart 1920; 7: 353–370
   Google Scholar
• Becker A. E., Grinspoon S. K., Klibanski A. Eating disorders. N. Engl. J. Med. 1999; 340: 1092–1098
   PubMed Web of Science ®Google Scholar
• Bowen S. E., Daniel J., Balster R. L. Death associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend. 1999; 53: 239–245
   PubMed Web of Science ®Google Scholar
• Brignole M., Alboni P., Benditt D. G., et al. ESC Guidelines on Management (Diagnosis and Treatment) of Syncope Update 2004. The Task Force on Syncope, European Society of Cardiology. Eur. Heart J 2004; 25: 2054–2072
   PubMed Web of Science ®Google Scholar
• Buja G., Miorelli M., Turrini P., et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am. J. Cardiol. 1993; 72: 973–976
   PubMed Web of Science ®Google Scholar
• Carder J. R., Fuerst R. S. Myocardial infarction after toluene inhalation. Pediatr. Emerg. Care 1997; 13: 117–119
   PubMed Web of Science ®Google Scholar
• Cardoso C., Salles G., Bloch K., Deccache W., et al. Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int. J. Cardiol. 2001; 79: 253–262
   PubMed Web of Science ®Google Scholar
• Choy A. M., Lang C. C., Roden D. M., et al. Abnormalities of the QT interval in primary disorders of autonomic failure. Am. Heart J. 1998; 136: 664–671
   PubMedGoogle Scholar
• Cruz S. L., Orta-Salazar G., Gauthereau M. Y., et al. Inhibition of cardiac sodium currents by toluene exposure. Br. J. Pharmacol. 2003; 140: 653–660
   PubMed Web of Science ®Google Scholar
• Darbar D., Luck J., Davidson N., et al. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. Br. Med. J. 1996; 312: 874–878
   PubMedGoogle Scholar
• Day C. P., McComb J. M., Campbell R. W. F. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. Br. Heart J. 1990; 63: 342–344
   PubMedGoogle Scholar
• Fitzpatrick A. P., Theodorakis G., Vardas P., et al. Methodology of head-up tilt testing in patients with unexplained syncope. J. Am. Coll. Cardiol. 1991; 17: 125–130
   PubMed Web of Science ®Google Scholar
• Flanagan R. J., Ruprah M., Meredith T. J., et al. An introduction to the clinical toxicology of volatile substances. Drug Safety 1990; 5: 359–383
   PubMed Web of Science ®Google Scholar
• Fu G. S., Meissner A., Simon R. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function. Eur. Heart J. 1997; 18: 281–289
   PubMedGoogle Scholar
• Glancy J. M., Weston P. J., Bhullar H. K., et al. Reproducibility and automatic measurement of QT dispersion. Eur. Heart J. 1996; 17: 1035–1039
   PubMedGoogle Scholar
• Henry W. L., DeMaria A., Gramiak R., et al. Report of the American Society of Echocardiography Committe on Nomenclature and Standards in Two Dimensional Echocardiography. Circulation 1980; 62: 212–217
   PubMed Web of Science ®Google Scholar
• Lisowska A., Skibinska E., Musial W. J. Severe heart failure due to toxic cardiomyopathy in a young patient. A case report. Kardiol. Pol 2004; 60: 372–373
   PubMedGoogle Scholar
• Lof A., Wigaeus Hjelm E., Colmsjo A., et al. Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br. J. Ind. Med. 1993; 50: 55–59
   PubMedGoogle Scholar
• Manttari M., Oikarinen L., Manninen V., et al. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997; 78: 268–272
   PubMed Web of Science ®Google Scholar
• Meadows R., Verghese A. Medical complications of glue sniffing. South. Med. J. 1996; 89: 455–462
   PubMed Web of Science ®Google Scholar
• Murakawa Y., Inoue H., Nozaki A., et al. Role of sympathovagal interaction in diurnal variation of QT intreval. Am. J. Cardiol. 1992; 69: 339–343
   PubMed Web of Science ®Google Scholar
• Murata K., Aaraki S., Yokoyama Y. Cardiac autonomic dysfunction in rotogravure printers exposed to toluene in relation to peripheral nerve conduction. Ind. Health 1993; 31: 79–90
   PubMed Web of Science ®Google Scholar
• Ögel K., Tamar D., Çakmak D. A look to Turkey's situation regarding to substance abuse problem. Turk. J. Psychiatry 1998; 9: 301–307
   Google Scholar
• Perkiomaki J. S., Koistinen M. J., Yli-Mayry S., et al. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J. Am. Coll. Cardiol. 1995; 26: 174–179
   PubMed Web of Science ®Google Scholar
• Ramsey J., Anderson H. R., Bloor K., et al. An introduction to the practice, prevalence and chemical toxicology of volatile substance abuse. Hum. Toxicol. 1989; 8: 261–269
   PubMedGoogle Scholar
• Sharp C. W., Rosenberg N. L. Inhalants. Substance abuse. A comprehensive textbook, J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams & Wilkins, Baltimore, MD 1997; 246–264
   Google Scholar
• Shepherd R. T. Mechanism of sudden death associated with volatile substance abuse. Hum. Toxicol. 1989; 8: 287–292
   PubMedGoogle Scholar
• Tran H. J., Fan C. H., Tu W. Q., et al. QT measurement: A comparison of three simple methods. Ann. Noninvas. Electrocardiol. 1998; 3: 228–231
   Google Scholar
• U.S. Department of Health and Human Services. Monitoring the future survey release. Smoking among teenagers decreases sharply and increase in ecstasy use slows. U.S. Department of Health and Human Services HHS News 2001, www.nida.nih.gov/MedAdv/01/NR12-19.html December 19. Retrieved July 3, 2003, from
   Google Scholar
• Vural M., Ogel K. Dilated cardiomyopathy associated with toluene abuse. Cardiology 2006; 105: 158–161
   PubMedGoogle Scholar
• Vervaet P., Amery W. Reproducibility of QTc-measurements in healty volunteers. Acta Cardiol 1993; 48(6)555–564
   PubMedGoogle Scholar
• Zareba W., Moss A. J., le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am. J. Cardiol. 1994; 74: 550–553
   PubMed Web of Science ®Google Scholar